XTalks
NOVEMBER 30, 2023
New FDA-Approved Treatments For HIV HIV treatment involves the administration of combined antiretroviral therapy (ART) to effectively suppress the viral load, maintain or enhance immune function and reduce the risk of opportunistic infections and cancers commonly associated with HIV. aiming to end the HIV epidemic by 2030.
The Pharma Data
DECEMBER 10, 2020
The vaccine targeted both the inner nucleocapsid (N) and the outer spike (S) proteins of the virus to maximize the immune response. The study showed this broad immune response led to the complete clearance of the virus in a matter of days after infection of previously-vaccinated primates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
DECEMBER 13, 2020
In July 2017, the US FDA approved sofosbuvir/velpatasvir/voxilaprevir? In August 2017, the US FDA approved glecaprevir/pibrentasvir (Mavyret) to treat adults with HCV genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.
Drug Discovery World
APRIL 14, 2023
He is being recognised for his inspiring contributions to genomic studies dedicated to analysing therapeutic response rates in multi-ethnic paediatric acute lymphoblastic leukaemia patient populations, which have resulted in the identification of a large number of genomic loci responsible for driving therapeutic response variability.
XTalks
DECEMBER 17, 2021
Developing a highly effective vaccine against malaria has been technically challenging because malaria has a large and complex genome, and it’s why it’s generally more difficult to develop a vaccine against parasites than smaller viruses and bacteria. Young children are most affected by the deadly disease in the continent of Africa.
The Pharma Data
OCTOBER 14, 2020
Additionally, immunogenicity, duration of immune response and occurrence of symptomatic COVID-19 will be measured. Risks and uncertainties related to these endeavors include, but are not limited to, obtaining FDA approval of NantKwest’s NK cells and MSC as well as other therapeutics and manufacturing challenges.
Drug Discovery World
MAY 11, 2023
Another dangerous consequence can occur when the therapeutic or vaccine introduces proteins that can activate an uncontrolled immune response. In the case of therapeutics, the aim is usually to avoid patients’ immune responses. Impurities can integrate into the final product at various points during production.
Expert insights. Personalized for you.
111 
Let's personalize your content